0001387131-22-012291.txt : 20221209 0001387131-22-012291.hdr.sgml : 20221209 20221209182247 ACCESSION NUMBER: 0001387131-22-012291 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221206 FILED AS OF DATE: 20221209 DATE AS OF CHANGE: 20221209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zanganeh Mahkam CENTRAL INDEX KEY: 0001507650 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36866 FILM NUMBER: 221455839 MAIL ADDRESS: STREET 1: 51 ADAM WAY CITY: ATHERTON STATE: CA ZIP: 94027 FORMER NAME: FORMER CONFORMED NAME: Zanganeh Maky DATE OF NAME CHANGE: 20101210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics Inc. CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2882 SAND HILL ROAD STREET 2: SUITE 106 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 617-514-7149 MAIL ADDRESS: STREET 1: 2882 SAND HILL ROAD STREET 2: SUITE 106 CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: Summit Therapeutics plc DATE OF NAME CHANGE: 20150219 FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 4 1 zangeneh-form4_120622.xml X0306 4 2022-12-06 0 0001599298 Summit Therapeutics Inc. SMMT 0001507650 Zanganeh Mahkam 51 ADAM WAY ATHERTON CA 94027 1 1 0 0 Co-CEO & President Common Stock 2022-12-06 4 J 0 373857 A 10930849 D 373,857 shares of Common Stock were issued to the Reporting Person as payment of interest in connection with a Note Purchase Agreement, dated December 6, 2022, by and among the Issuer, the Reporting Person and Robert W. Duggan. The determination of the number of shares of Common Stock to be issued to the Reporting Person was based on a per share price of $0.79. /s/ Mahkam Zanganeh 2022-12-09